AAO

Brolucizumab demonstrated superior anatomic results and maintained best corrected visual acuity (BCVA) in patients with polypoidal choroidal vasculopathy (PCV) at week 96 of the HAWK study compared with aflibercept.

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Onabotulinumtoxin A (BoNT-A) injections improved…

Faricimab showed sustained anatomic and visual outcomes at extended dosing intervals (every 16 or 12 weeks) compared with ranibizumab dosed every 4 weeks for neovascular age-related macular degeneration.

Intravitreal risuteganib demonstrated statistical significance compared to sham injection in patients with intermediate nonexudative age-related macular degeneration, according to new study.

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Preservative-free latanoprost proved to be…

Compared with as needed treatment, monthly intravitreal injection of ranibizumab was associated with a statistically significant gain in vision in patients with radiation retinopathy-related macular edema.

Dexamethasone intravitreal implant was found to be effective in patients with diabetic macular edema who were nonresponders to anti-vascular endothelial growth factor (VEGF) therapy, according to data

Patients who receive intravitreal injections for retinal diseases may experience physical and psychosocial challenges, according to survey results

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – For patients with progressive Acanthamoeba…

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – Among patients with neuropathic corneal…